Answers are grounded in this paper and cite their sources.
Rare disorders, defined as having fewer than 200,000 affected individuals in the United States, present unique challenges due to their rarity. Few single institutions possess the comprehensive experience, clinical expertise, advocacy, and research background necessary to optimize patient care for those affected by a variety of rare disorders. The National Organization for Rare Disorders (NORD ® ), an umbrella organization advocating for all rare disease groups, has designated 49 Rare Disease Centers of Excellence (RD CoE), representing more than 170 academic medical and research institutions. These designated centers demonstrate broad rare disease capacity across facilities, clinical expertise, research, advocacy, and experience in managing rare diseases. NORD’s RD CoE framework fosters collaboration aimed at improving care for individuals with rare diseases. Given the complexities of rare diseases, the Network provides a structure for connecting institutions and is developing infrastructure intended to facilitate multi-institutional studies, appropriate data sharing, collaborative protocol development, and broader participation in rare disease clinical research. It also connects academic centers with patient organizations and other partners to support research, education, and therapeutic implementation. This paper describes the creation, selection process, governance, and early collaborative infrastructure of the NORD RD CoE Network.
No takes yet. Share an insight, caveat, or question.
Karaa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: